Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

INBPINTEGRATED BIOPHARMA INC

OTC · CIK 0001016504
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end0630
XBRL facts377

Identity from submissions API

NameINTEGRATED BIOPHARMA INC
CIK0001016504
TickersINBP
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN222407475
LEI—
Fiscal year end0630
State of incorporationDE DE
Phone9739260816
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • INTEGRATED HEALTH TECHNOLOGIES INC (2002-09-12T00:00:00.000Z → 2003-04-16T00:00:00.000Z)
  • CHEM INTERNATIONAL INC (1996-12-09T00:00:00.000Z → 2002-05-14T00:00:00.000Z)
Business address
225 LONG AVENUE
BUILDING 15
HILLSIDE
NJ
07205
NJ
Mailing address
225 LONG AVENUE
BUILDING 15
HILLSIDE
NJ
07205
NJ

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

559 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 8-K FORM 8-K 2.02,9.01 0001437749-26-036730 001-31668 261550465 34 226654 1 1
2026-11-13 10-Q FORM 10-Q 0001437749-26-036725 001-31668 261550324 34 4686159 1 1
2026-10-28 DEF 14A FORM DEF 14A 0001437749-26-033764 001-31668 261495276 34 1222383 1 1
2026-09-25 8-K FORM 8-K 2.02,9.01 0001437749-26-031247 001-31668 261411169 34 259779 1 1
2026-09-25 10-K FORM 10-K 0001437749-26-031241 001-31668 261410876 34 7325311 1 1
2026-08-20 8-K FORM 8-K 8.01 0001437749-26-028628 001-31668 261299494 34 189123 1 1
2026-07-02 8-K FORM 8-K PNC FIRST AMENDMENT 1.01,1.02,9.01 0001437749-26-022415 001-31668 261148623 34 345699 1 1
2026-06-25 4/A PRIMARY DOCUMENT 0001216280-26-000002 5975
2026-06-25 4 PRIMARY DOCUMENT 0001345281-26-000008 5608
2026-06-25 4 PRIMARY DOCUMENT 0001216280-26-000001 5738
2026-06-25 4 PRIMARY DOCUMENT 0001382218-26-000001 5654
2026-06-25 4 PRIMARY DOCUMENT 0001443194-26-000006 5615
2026-05-08 8-K FORM 8-K 2.02,9.01 0001437749-26-015928 001-31668 26959000 34 259521 1 1
2026-05-08 10-Q FORM 10-Q 0001437749-26-015899 001-31668 26958318 34 6103152 1 1
2026-04-17 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001102948-26-000006 005-52311 26871805 34 342992
2026-04-17 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001345281-26-000007 005-52311 26871361 34 337640
2026-04-17 4/A PRIMARY DOCUMENT 0001443194-26-000005 7334
2026-04-17 4 PRIMARY DOCUMENT 0001443194-26-000004 7100
2026-04-17 4 PRIMARY DOCUMENT 0001102948-26-000002 7089
2026-04-17 4 PRIMARY DOCUMENT 0001345281-26-000004 7011
2026-04-15 8-K FORM 8-K 8.01,9.01 0001437749-26-012368 001-31668 26863985 34 158057 1 1
2026-03-26 4 PRIMARY DOCUMENT 0001102948-26-000001 7677
2026-03-25 4 PRIMARY DOCUMENT 0001443194-26-000003 7700
2026-03-25 4 PRIMARY DOCUMENT 0001345281-26-000001 7002
2026-02-18 8-K FORM 8-K 1.01,9.01 0001437749-26-004553 001-31668 26648691 34 184846 1 1
2026-02-11 8-K FORM 8-K 2.02,9.01 0001437749-26-003808 001-31668 26621353 34 259882 1 1
2026-02-11 10-Q FORM 10-Q 0001437749-26-003803 001-31668 26621079 34 5824818 1 1
2025-12-10 4 PRIMARY DOCUMENT 0001064901-25-000002 5511
2025-12-10 4 PRIMARY DOCUMENT 0001064900-25-000002 5593
2025-12-10 4 PRIMARY DOCUMENT 0001345281-25-000011 5498
2025-12-01 8-K FORM 8-K 5.07,9.01 0001437749-25-036573 001-31668 251540715 34 173825 1 1
2025-11-10 8-K FORM 8-K 2.02,9.01 0001437749-25-034091 001-31668 251465974 34 226434 1 1
2025-11-10 10-Q FORM 10-Q 0001437749-25-034076 001-31668 251465875 34 4614662 1 1
2025-10-28 DEF 14A FORM DEF 14A 0001437749-25-031864 001-31668 251421678 34 968011 1 1
2025-09-23 8-K FORM 8-K 2.02,9.01 0001437749-25-029717 001-31668 251333502 34 259164 1 1
2025-09-23 10-K FORM 10-K 0001437749-25-029711 001-31668 251333408 34 7039739 1 1
2025-06-20 4 PRIMARY DOCUMENT 0001345281-25-000009 5537
2025-06-20 4 PRIMARY DOCUMENT 0001345281-25-000008 5510
2025-06-20 4 PRIMARY DOCUMENT 0001345281-25-000007 5566
2025-06-20 4 PRIMARY DOCUMENT 0001345281-25-000006 5558
2025-05-30 4 PRIMARY DOCUMENT 0001345281-25-000005 7384
2025-05-22 4 PRIMARY DOCUMENT 0001345281-25-000004 7531
2025-05-22 4 PRIMARY DOCUMENT 0001345281-25-000003 7449
2025-05-22 4 PRIMARY DOCUMENT 0001345281-25-000002 7435
2025-05-22 4 PRIMARY DOCUMENT 0001345281-25-000001 7436
2025-05-14 8-K FORM 8-K 2.02,9.01 0001437749-25-016809 001-31668 25944940 34 271275 1 1
2025-05-14 10-Q FORM 10-Q 0001437749-25-016802 001-31668 25944820 34 5845783 1 1
2025-04-24 8-K FORM 8-K 4.01,9.01 0001437749-25-012917 001-31668 25866690 34 167754 1 1
2025-04-21 8-K FORM 8-K 1.01,1.02,2.03,9.01 0001437749-25-012475 001-31668 25852358 34 818672 1 1
2025-02-13 8-K FORM 8-K 2.02,9.01 0001437749-25-003765 001-31668 25620891 34 265631 1 1
2025-02-13 10-Q FORM 10-Q 0001437749-25-003744 001-31668 25619843 34 5359811 1 1
2024-12-05 4 PRIMARY DOCUMENT 0001064901-24-000001 5518
2024-12-05 4 PRIMARY DOCUMENT 0001064900-24-000002 5600
2024-12-05 4 PRIMARY DOCUMENT 0001345281-24-000007 5512
2024-12-02 8-K FORM 8-K 5.07,9.01 0001437749-24-036441 001-31668 241518537 34 168555 1 1
2024-11-25 4 PRIMARY DOCUMENT 0001064900-24-000001 7344
2024-11-25 4 PRIMARY DOCUMENT 0001345281-24-000006 7262
2024-11-25 4 PRIMARY DOCUMENT 0001345281-24-000005 7248
2024-11-14 8-K FORM 8-K 2.02,9.01 0001437749-24-035331 001-31668 241463004 34 231190 1 1
2024-11-13 10-Q FORM 10-Q 0001437749-24-034953 001-31668 241455322 34 4504432 1 1
2024-10-28 DEF 14A FORM DEF 14A 0001437749-24-032295 001-31668 241401046 34 526451
2024-09-23 8-K FORM 8-K 2.02,9.01 0001437749-24-029810 001-31668 241315140 34 261923 1 1
2024-09-20 10-K FORM 10-K 0001437749-24-029768 001-31668 241313903 34 6693998 1 1
2024-08-08 4 PRIMARY DOCUMENT 0001345281-24-000004 5545
2024-08-08 4 PRIMARY DOCUMENT 0001345281-24-000003 5575
2024-08-08 4 PRIMARY DOCUMENT 0001345281-24-000002 5516
2024-08-08 4 PRIMARY DOCUMENT 0001345281-24-000001 5566
2024-05-10 8-K FORM 8-K 2.02,9.01 0001437749-24-016041 001-31668 24935598 34 264721 1 1
2024-05-10 10-Q FORM 10-Q 0001437749-24-016015 001-31668 24935137 34 5703683 1 1
2024-02-12 8-K FORM 8-K 2.02,9.01 0001437749-24-003763 001-31668 24620479 34 256208 1 1
2024-02-12 10-Q FORM 10-Q 0001437749-24-003756 001-31668 24620138 34 5229561 1 1
2023-11-29 4 PRIMARY DOCUMENT 0001345281-23-000009 5519
2023-11-29 4 PRIMARY DOCUMENT 0001345281-23-000008 5437
2023-11-29 4 PRIMARY DOCUMENT 0001345281-23-000007 5424
2023-11-27 8-K FORM 8-K 5.07,9.01 0001437749-23-033049 001-31668 231440014 34 173693 1 1
2023-11-16 SC 13D SCHEDULE 13D 0001437749-23-032344 005-52311 231414832 34 37271
2023-11-16 5 PRIMARY DOCUMENT 0001345281-23-000006 16613
2023-11-16 3 PRIMARY DOCUMENT 0001345281-23-000005 7437
2023-11-14 SC 13D SCHEDULE 13D 0001437749-23-031869 005-52311 231403649 34 97018
2023-11-09 8-K FORM 8-K 2.02,9.01 0001437749-23-031188 001-31668 231391783 34 226192 1 1
2023-11-09 10-Q FORM 10-Q 0001437749-23-031168 001-31668 231391660 34 4562136 1 1
2023-10-27 DEF 14A FORM DEF 14A 0001437749-23-029180 001-31668 231353441 34 536288
2023-09-21 4 PRIMARY DOCUMENT 0001064900-23-000002 17404
2023-09-21 4 PRIMARY DOCUMENT 0001064901-23-000002 17053
2023-09-21 4 PRIMARY DOCUMENT 0001345281-23-000004 7451
2023-09-15 8-K FORM 8-K 2.02,9.01 0001437749-23-026058 001-31668 231259513 34 262520 1 1
2023-09-15 10-K FORM 10-K 0001437749-23-026022 001-31668 231258928 34 6995637 1 1
2023-07-20 4 PRIMARY DOCUMENT 0001345281-23-000003 5649
2023-07-19 4 PRIMARY DOCUMENT 0001345281-23-000002 5706
2023-07-19 4 PRIMARY DOCUMENT 0001345281-23-000001 5676
2023-07-19 4 PRIMARY DOCUMENT 0001382218-23-000001 5697
2023-06-01 4 PRIMARY DOCUMENT 0001064900-23-000001 5091
2023-06-01 4 PRIMARY DOCUMENT 0001064901-23-000001 5009
2023-05-11 8-K FORM 8-K 2.02,9.01 0001437749-23-013899 001-31668 23910629 34 261774 1 1
2023-05-11 10-Q FORM 10-Q 0001437749-23-013885 001-31668 23910534 34 5953698 1 1
2023-03-21 8-K FORM 8-K 8.01,9.01 0001437749-23-007377 001-31668 23749465 34 179283 1 1
2023-03-17 8-K FORM 8-K 1.01 0001437749-23-007022 001-31668 23741533 34 160976 1 1
2023-02-10 8-K FORM 8-K 2.02,9.01 0001437749-23-003052 001-31668 23613189 34 265745 1 1
2023-02-10 10-Q FORM 10-Q 0001437749-23-003051 001-31668 23612591 34 5773271 1 1
2022-12-06 8-K FORM 8-K 1.01 0001437749-22-028569 001-31668 221448303 34 158107 1 1
2022-11-28 8-K FORM 8-K 5.07 0001437749-22-028094 001-31668 221423822 34 166886 1 1
2022-11-14 8-K/A FORM 8-K/A 2.02,9.01 0001437749-22-027367 001-31668 221387617 34 239455 1 1
2022-11-14 8-K FORM 8-K 2.02,9.01 0001437749-22-027168 001-31668 221383327 34 233870 1 1
2022-11-10 4 PRIMARY DOCUMENT 0001064901-22-000001 5712
2022-11-10 4 PRIMARY DOCUMENT 0001064900-22-000001 5794
2022-11-10 4 PRIMARY DOCUMENT 0001053310-22-000003 5723
2022-11-10 4 PRIMARY DOCUMENT 0001345281-22-000003 5699
2022-11-10 10-Q FORM 10-Q 0001437749-22-026976 001-31668 221378684 34 4310519 1 1
2022-10-27 DEF 14A FORM DEF 14A 0001437749-22-024952 001-31668 221337564 34 513314
2022-10-24 8-K FORM 8-K 4.01,9.01 0001437749-22-024634 001-31668 221326570 34 163841 1 1
2022-09-14 8-K FORM 8-K 2.02,9.01 0001437749-22-022390 001-31668 221242366 34 262892 1 1
2022-09-13 10-K FORM 10-K 0001437749-22-022334 001-31668 221241343 34 7036434 1 1
2022-07-15 8-K FORM 8-K 1.01,1.02 0001437749-22-017194 001-31668 221087453 34 160933 1 1
2022-06-21 4 PRIMARY DOCUMENT 0001345281-22-000002 5644
2022-06-21 3 PRIMARY DOCUMENT 0001345281-22-000001 3070
2022-06-21 8-K FORM 8-K 5.02 0001437749-22-015503 001-31668 221029022 34 185767 1 1
2022-06-21 4 PRIMARY DOCUMENT 0001216280-22-000001 5674
2022-06-21 4 PRIMARY DOCUMENT 0001443194-22-000001 5617
2022-06-21 4 PRIMARY DOCUMENT 0001382218-22-000001 5665
2022-05-12 8-K FORM 8-K 2.02,5.05,9.01 0001437749-22-012086 001-31668 22917211 34 338063 1 1
2022-05-12 10-Q FORM 10-Q 0001437749-22-012079 001-31668 22917137 34 5410781 1 1
2022-05-11 4/A PRIMARY DOCUMENT 0001053310-22-000002 7451
2022-05-06 4 PRIMARY DOCUMENT 0001053310-22-000001 4880
2022-02-10 8-K FORM 8-K 2.02,9.01 0001437749-22-003026 001-31668 22614625 34 264848 1 1
2022-02-10 10-Q FORM 10-Q 0001437749-22-002980 001-31668 22613097 34 5246711 1 1
2021-11-29 8-K FORM 8-K 5.07,9.01 0001437749-21-027467 001-31668 211455875 34 173891 1 1
2021-11-10 8-K FORM 8-K 2.02,9.01 0001437749-21-026193 001-31668 211397585 34 232507 1 1
2021-11-10 10-Q FORM 10-Q 0001437749-21-026177 001-31668 211397270 34 4268554 1 1
2021-11-04 4 PRIMARY DOCUMENT 0001443194-21-000001 5761
2021-11-04 4 PRIMARY DOCUMENT 0001102948-21-000001 5827
2021-11-04 4 PRIMARY DOCUMENT 0001053310-21-000001 5715
2021-11-03 4 PRIMARY DOCUMENT 0001345281-21-000003 5819
2021-11-03 4 PRIMARY DOCUMENT 0001345281-21-000002 5811
2021-11-03 4 PRIMARY DOCUMENT 0001345281-21-000001 5689
2021-11-03 4 PRIMARY DOCUMENT 0001064901-21-000001 5702
2021-11-03 4 PRIMARY DOCUMENT 0001064900-21-000001 5784
2021-10-27 DEF 14A FORM DEF 14A 0001437749-21-024366 001-31668 211352501 34 530755
2021-09-02 8-K FORM 8-K 2.02 0001437749-21-021383 001-31668 211232814 34 131280
2021-09-02 10-K FORM 10-K 0001437749-21-021375 001-31668 211232589 34 6038948 1
2021-07-07 8-K FORM 8-K 1.02 0001437749-21-016530 001-31668 211076579 34 22099
2021-05-13 8-K FORM 8-K 2.02 0001437749-21-011995 001-31668 21918635 34 132470
2021-05-13 10-Q FORM 10-Q 0001437749-21-011992 001-31668 21918591 34 4515719 1
2021-04-08 8-K FORM 8-K 8.01 0001437749-21-008538 001-31668 21814429 34 47828
2021-02-12 8-K FORM 8-K 2.02,9.01 0001437749-21-002790 001-31668 21626767 34 132609
2021-02-12 10-Q FORM 10-Q 0001437749-21-002781 001-31668 21626189 34 4653365 1
2021-01-22 8-K FORM 8-K 8.01 0001437749-21-001059 001-31668 21544312 34 49929
2020-11-30 8-K FORM 8-K 5.07 0001437749-20-024567 001-31668 201358723 34 34906
2020-11-20 4 PRIMARY DOCUMENT 0001345281-20-000008 5481
2020-11-20 4 PRIMARY DOCUMENT 0001345281-20-000007 5361
2020-11-20 4 PRIMARY DOCUMENT 0001345281-20-000006 5451
2020-11-20 4 PRIMARY DOCUMENT 0001345281-20-000005 5423
2020-11-20 4 PRIMARY DOCUMENT 0001345281-20-000004 5437
2020-11-20 4 PRIMARY DOCUMENT 0001345281-20-000003 5355
2020-11-20 4 PRIMARY DOCUMENT 0001345281-20-000002 5459
2020-11-20 4 PRIMARY DOCUMENT 0001345281-20-000001 5342
2020-11-17 3 PRIMARY DOCUMENT 0001216280-20-000003 3017
2020-11-12 8-K FORM 8-K 2.02 0001437749-20-023661 001-31668 201307430 34 101549
2020-11-12 10-Q FORM 10-Q 0001437749-20-023629 001-31668 201306928 34 3928058 1
2020-11-09 8-K FORM 8-K 5.02 0001437749-20-023251 001-31668 201298678 34 21691
2020-10-28 DEF 14A FORM DEF 14A 0001437749-20-021799 001-31668 201267613 34 430595
2020-09-24 8-K FORM 8-K 9.01 0001437749-20-020153 001-31668 201193878 34 100945
2020-09-23 10-K FORM 10-K 0001437749-20-020123 001-31668 201192635 34 6466982 1
2020-05-14 8-K FORM 8-K 2.02 0001437749-20-010640 001-31668 20874914 34 130515
2020-05-13 10-Q FORM 10-Q 0001437749-20-010595 001-31668 20873654 34 5238767 1
2020-02-12 8-K FORM 8-K 2.02 0001437749-20-002482 001-31668 20605695 34 131462
2020-02-12 10-Q FORM 10-Q 0001437749-20-002475 001-31668 20605010 34 4843659 1
2019-12-03 8-K FORM 8-K 5.07 0001437749-19-023781 001-31668 191264972 34 34598
2019-11-13 8-K FORM 8-K 2.02 0001437749-19-022671 001-31668 191213713 34 96704
2019-11-13 10-Q FORM 10-Q 0001437749-19-022660 001-31668 191213537 34 4096465 1
2019-10-28 DEF 14A FORM DEF 14A 0001437749-19-020729 001-31668 191172983 34 513986
2019-09-16 8-K FORM 8-K 2.03 0001437749-19-018448 001-31668 191093937 34 105820
2019-08-29 10-K FORM 10-K 0001437749-19-017611 001-31668 191065200 34 6953428 1
2019-05-29 4 PRIMARY DOCUMENT 0001102948-19-000001 5442
2019-05-29 4 PRIMARY DOCUMENT 0001443194-19-000001 5383
2019-05-29 4 PRIMARY DOCUMENT 0001053310-19-000001 5464
2019-05-29 4 PRIMARY DOCUMENT 0001064900-19-000001 5554
2019-05-29 4 PRIMARY DOCUMENT 0001064901-19-000001 5458
2019-05-29 4 PRIMARY DOCUMENT 0001382218-19-000001 5447
2019-05-29 4 PRIMARY DOCUMENT 0001345281-19-000001 5453
2019-05-29 8-K FORM 8-K 5.02 0001437749-19-010980 001-31668 19861211 34 23933
2019-05-15 8-K FORM 8-K 2.02,9.01 0001437749-19-010025 001-31668 19827263 34 145866
2019-05-15 10-Q FORM 10-Q 0001437749-19-010014 001-31668 19827148 34 5331764 1
2019-05-06 8-K FORM 8-K 5.02,9.01 0001437749-19-008829 001-31668 19799153 34 55293
2019-02-13 10-Q FORM 10-Q 0001437749-19-002460 001-31668 19597135 34 5045383 1
2018-12-28 S-8 FORM S-8 0001437749-18-022727 333-229069 181257400 33 111543
2018-12-19 4/A PRIMARY DOCUMENT 0001064901-18-000002 5088
2018-12-19 4/A PRIMARY DOCUMENT 0001064900-18-000002 5166
2018-12-19 4 PRIMARY DOCUMENT 0001053310-18-000001 4871
2018-12-19 4 PRIMARY DOCUMENT 0001064901-18-000001 4878
2018-12-19 4 PRIMARY DOCUMENT 0001064900-18-000001 4960
2018-11-26 8-K FORM 8-K 5.07 0001437749-18-021274 001-31668 181200798 34 31909
2018-11-09 10-Q FORM 10-Q 0001437749-18-020336 001-31668 181174174 34 4116913 1
2018-10-29 DEF 14A FORM DEF 14A 0001437749-18-018968 001-31668 181144065 34 362475
2018-09-12 10-K FORM 10-K 0001437749-18-016922 001-31668 181066961 34 6340974 1
2018-08-01 4 PRIMARY DOCUMENT 0001443197-18-000003 8791
2018-08-01 4 PRIMARY DOCUMENT 0001443197-18-000002 9063
2018-08-01 4 PRIMARY DOCUMENT 0001443197-18-000001 7836
2018-08-01 8-K FORM 8-K 1.02,3.02,9.01 0001437749-18-014197 001-31668 18985238 34 54636
2018-05-09 10-Q FORM 10-Q 0001437749-18-009219 001-31668 18818982 34 4499997 1
2018-02-09 10-Q FORM 10-Q 0001437749-18-002159 001-31668 18591805 34 4180092 1
2017-11-28 8-K FORM 8-K 5.07 0001437749-17-019834 001-31668 171223859 34 32503
2017-11-09 10-Q FORM 10-Q 0001437749-17-018907 001-31668 171191159 34 3304066 1
2017-10-27 DEF 14A FORM DEF 14A 0001437749-17-017725 001-31668 171158525 34 370714
2017-09-01 10-K FORM 10-K 0001437749-17-015520 001-31668 171065996 34 5889766 1
2017-05-10 10-Q FORM 10-Q 0001437749-17-008597 001-31668 17830083 34 3659717 1
2017-02-10 10-Q FORM 10-Q 0001437749-17-002119 001-31668 17593513 34 3330368 1
2016-11-28 8-K FORM 8-K 5.07 0001437749-16-042679 001-31668 162020644 34 24686
2016-11-23 8-K FORM 8-K 5.02 0001437749-16-042559 001-31668 162014989 34 18061
2016-11-22 4 PRIMARY DOCUMENT 0001382218-16-000003 5545
2016-11-22 4 PRIMARY DOCUMENT 0001644435-16-000002 5476
2016-11-22 4 PRIMARY DOCUMENT 0001102948-16-000003 5555
2016-11-22 4 PRIMARY DOCUMENT 0001443194-16-000003 5494
2016-11-10 10-Q FORM 10-Q 0001437749-16-041746 001-31668 161987891 34 3012514 1
2016-10-28 DEF 14A FORM DEF 14A 0001437749-16-040492 001-31668 161957089 34 381018
2016-09-02 10-K FORM 10-K 0001437749-16-038298 001-31668 161867552 34 5134143 1
2016-05-13 10-Q inb10q_20160331.htm 0001016504-16-000022 001-31668 161648143 34 4189719 1
2016-02-19 10-Q inb10q_20151231.htm 0001016504-16-000020 001-31668 161442813 34 4309145 1
2016-02-16 NT 10-Q inb12b25_20160216.htm 0001016504-16-000019 001-31668 161430004 34 21765
2015-11-30 8-K inb8k_20151130.htm 5.07 0001016504-15-000016 001-31668 151260048 34 35632
2015-11-05 10-Q inb10q_20150930.htm 0001016504-15-000014 001-31668 151200220 34 3754720 1
2015-10-26 DEF 14A inbproxy2015.htm 0001016504-15-000012 001-31668 151175684 34 955312
2015-09-04 10-K inb10k_20150630.htm 0001016504-15-000010 001-31668 151094352 34 7841776 1
2015-06-09 3 PRIMARY DOCUMENT 0001644435-15-000001 4151
2015-06-09 4 PRIMARY DOCUMENT 0001064900-15-000003 5513
2015-06-05 4 PRIMARY DOCUMENT 0001382218-15-000002 5421
2015-06-05 4 PRIMARY DOCUMENT 0001064901-15-000003 5431
2015-06-05 8-K inb8k_20150605.htm 5.02 0001016504-15-000008 001-31668 15915374 34 34281
2015-06-04 4 PRIMARY DOCUMENT 0001345281-15-000001 5398
2015-06-04 4 PRIMARY DOCUMENT 0001053310-15-000002 5421
2015-06-03 4 PRIMARY DOCUMENT 0001102948-15-000001 5432
2015-06-03 4 PRIMARY DOCUMENT 0001443194-15-000001 5372
2015-05-14 10-Q inb10q_20150331.htm 0001016504-15-000006 001-31668 15863013 34 7486392 1
2015-02-17 10-Q inb10q_20141231.htm 0001016504-15-000004 001-31668 15624516 34 7450828 1
2014-12-01 8-K inb8k_20141201.htm 5.07 0001016504-14-000016 001-31668 141257311 34 73908
2014-11-07 10-Q inb10q_20140930.htm 0001016504-14-000013 001-31668 141204599 34 6972979 1
2014-10-28 DEF 14A inbproxy2014.htm 0001016504-14-000012 001-31668 141177893 34 1184870
2014-09-08 10-K inb10k_20140630.htm 0001016504-14-000008 001-31668 141091691 34 9777978 1
2014-05-14 10-Q inb10q_20140331.htm 0001016504-14-000006 001-31668 14841205 34 7580901 1
2014-02-13 10-Q/A inb10qa_20131231.htm 0001016504-14-000004 001-31668 14603945 34 5574104 1
2014-02-12 10-Q inb10q_20131231.htm 0001016504-14-000002 001-31668 14601248 34 1985908
2013-12-02 8-K inb8k_20131202.htm 5.07 0001016504-13-000019 001-31668 131252161 34 84777
2013-11-14 10-Q inb10q_20130930.htm 0001016504-13-000017 001-31668 131220195 34 6127821 1
2013-11-06 DEFA14A inb_proxy2013a1.htm 0001016504-13-000015 001-31668 131196775 34 1113028
2013-10-28 DEF 14A inb_proxy2013.htm 0001016504-13-000013 001-31668 131172995 34 1110864
2013-09-30 10-K inb10k_20130630.htm 0001016504-13-000011 001-31668 131123303 34 10145716 1
2013-05-15 10-Q inb10q_20130331.htm 0001016504-13-000006 001-31668 13844697 34 4012329 1
2013-02-19 10-Q inb10q_20121231.htm 0001016504-13-000004 001-31668 13623639 34 3725582 1
2013-02-14 NT 10-Q inb12b25_20130214.htm 0001016504-13-000003 001-31668 13614707 34 24705
2012-11-27 8-K inb8k_20121126.htm 5.07 0001016504-12-000032 001-31668 121226209 34 49797
2012-11-19 10-Q inb10q_20120930.htm 0001016504-12-000030 001-31668 121215721 34 3495509 1
2012-11-14 NT 10-Q inb12b25_20121112.htm 0001016504-12-000028 001-31668 121203786 34 24678
2012-11-05 DEFA14A inb_proxy2012a.htm 0001016504-12-000026 001-31668 121179215 34 467027
2012-10-29 DEF 14A inb_proxy2012.htm 0001016504-12-000024 001-31668 121165563 34 465616
2012-10-15 10-K inb10k_20120630.htm 0001016504-12-000022 001-31668 121144365 34 8620091 1
2012-09-28 NT 10-K inb12b25_20120928.htm 0001016504-12-000020 001-31668 121117345 34 25064
2012-07-11 D xslFormDX01/primary_doc.xml 06 0001140361-12-032877 021-181032 12957415 33 10593
2012-07-05 4 FORM 4 0001140361-12-032458 44145
2012-07-05 3 PRIMARY DOCUMENT 0001443197-12-000001 5716
2012-06-29 4 PRIMARY DOCUMENT 0001443194-12-000001 27273
2012-06-29 4 PRIMARY DOCUMENT 0001102948-12-000002 27532
2012-06-29 4 PRIMARY DOCUMENT 0001053310-12-000001 5111
2012-06-29 8-K inb8k_20120628.htm 1.01,1.02,2.03,9.01 0001016504-12-000017 001-31668 12936253 34 2863096
2012-05-21 10-Q inb10q_20120521.htm 0001016504-12-000015 001-31668 12859440 34 2865345 1
2012-05-16 NT 10-Q inb12b25_20120515.htm 0001016504-12-000013 001-31668 12846744 34 24558
2012-02-21 10-Q inb10q_20111231.htm 0001016504-12-000011 001-31668 12627816 34 2018947 1
2012-02-14 NT 10-Q inb12b25_20120214.htm 0001016504-12-000009 001-31668 12610514 34 24173
2012-02-03 8-K inb8k_20120203.htm 1.01,9.01 0001016504-12-000007 001-31668 12570479 34 49293
2012-01-26 8-K inb8k_20120124.htm 1.01,9.01 0001016504-12-000005 001-31668 12548036 34 63851
2012-01-12 8-K inb8k_20120113.htm 1.01,9.01 0001016504-12-000003 001-31668 12524162 34 61154
2012-01-05 8-K inb8k_20111230.htm 1.01,9.01 0001016504-12-000001 001-31668 12512194 34 63931
2011-11-28 8-K inb8k_20111128.htm 5.07 0001016504-11-000019 001-31668 111228982 34 47310
2011-11-21 10-Q inb10q_201109302.htm 0001016504-11-000017 001-31668 111219795 34 2016162 1
2011-11-14 NT 10-Q inb12b25_20111114.htm 0001016504-11-000015 001-31668 111202471 34 24022
2011-10-28 DEF 14A inb_proxy2011.htm 0001016504-11-000013 001-31668 111165747 34 522712
2011-10-13 10-K inb10k_20110630a.htm 0001016504-11-000011 001-31668 111139983 34 916968
2011-10-11 8-K inb8k_20111010.htm 1.01,9.01 0001016504-11-000010 001-31668 111136031 34 103324
2011-09-28 NT 10-K inb12b25_20110928.htm 0001016504-11-000008 001-31668 111111051 34 24047
2011-05-17 10-Q inb10q_20110331.htm 0001016504-11-000006 001-31668 11852248 34 1248567
2011-05-16 NT 10-Q inb12b25_20110516.htm 0001016504-11-000005 001-31668 11848049 34 24583
2011-02-14 10-Q inb10q_20101231.htm 0001016504-11-000003 001-31668 11610609 34 508740
2010-11-30 8-K inb8k_20101130.htm 5.07,8.01 0001016504-10-000021 001-31668 101221039 34 40930
2010-11-15 10-Q inb10q_20100930.htm 0001016504-10-000018 001-31668 101192953 34 598779
2010-10-28 DEF 14A inbproxy2010.htm 0001016504-10-000016 001-31668 101147976 34 515399
2010-09-29 10-K/A inb10ka_20100630.htm 0001016504-10-000014 001-31668 101094747 34 81706
2010-09-28 10-K inb10k_20100630.htm 0001016504-10-000012 001-31668 101094315 34 940615
2010-05-19 10-Q/A inb10qa_20100519.htm 0001016504-10-000008 001-31668 10845225 34 73331
2010-05-19 10-Q inb10q_20100331.htm 0001016504-10-000006 001-31668 10844899 34 557829
2010-05-17 NT 10-Q inb12b25_20100517.htm 0001016504-10-000005 001-31668 10840062 34 27884
2010-02-12 10-Q inb10q_20100211.htm 0001016504-10-000002 001-31668 10600918 34 1466686
2009-11-25 ARS AUTO-GENERATED PAPER DOCUMENT 9999999997-09-027068 001-31668 09012553 34 1874
2009-11-19 10-Q inb10q_20091119.htm 0001016504-09-000035 001-31668 091196380 34 652131
2009-11-16 NT 10-Q inbnt10q_20091116.htm 0001016504-09-000033 001-31668 091187815 34 21302
2009-11-02 DEFR14A inbproxy_2009a.htm 0001016504-09-000031 001-31668 091151919 34 894918
2009-11-02 8-K inb8k_20091102.htm 4.01,9.01 0001016504-09-000030 001-31668 091151910 34 22031
2009-10-28 DEF 14A inbproxy_2009.htm 0001016504-09-000028 001-31668 091142249 34 863536
2009-10-28 4 xslF345X03/carldesantis_ex.xml 0001016504-09-000027 14628
2009-10-28 4 xslF345X03/rivasheppard_ex.xml 0001016504-09-000026 5474
2009-10-28 4 xslF345X03/geraldkay_ex.xml 0001016504-09-000025 5469
2009-10-28 4 xslF345X03/robertcanarick_ex.xml 0001016504-09-000024 5563
2009-10-28 4 xslF345X03/christinakay_ex.xml 0001016504-09-000023 5484
2009-10-28 4 xslF345X03/dinamasi_ex.xml 0001016504-09-000022 5568
2009-10-13 10-K inb10k_20090630.htm 0001016504-09-000020 001-31668 091116405 34 968165
2009-09-28 NT 10-K inb12b_20090928.htm 0001016504-09-000018 001-31668 091090727 34 21650
2009-05-21 10-Q/A inb10qa_20090331.htm 0001016504-09-000016 001-31668 09843736 34 663878
2009-05-20 10-Q inb10q_20090331.htm 0001016504-09-000015 001-31668 09843517 34 655642
2009-05-15 NT 10-Q inb12b_20090514.htm 0001016504-09-000013 001-31668 09834019 34 21666
2009-04-13 25 inb25_20090410.htm 0001016504-09-000011 001-31668 09746610 34 23455
2009-04-13 8-K inb8k_20090413.htm 3.01,9.01 0001016504-09-000010 001-31668 09746562 34 21120
2009-04-08 8-K inb8k_20090407.htm 5.02,9.01 0001016504-09-000008 001-31668 09739509 34 23645
2009-03-26 8-K FORM 8-K 5.02 0001019056-09-000375 001-31668 09705072 34 8536
2009-03-24 8-K FORM 8-K 1.01,2.01,2.05,9.01 0001019056-09-000370 001-31668 09701275 34 122044
2009-03-02 8-K inb8k_20090302.htm 5.02 0001016504-09-000006 001-31668 09646276 34 13956
2009-02-20 10-Q inb10q_20081231.htm 0001016504-09-000004 001-31668 09626075 34 701836
2009-02-17 NT 10-Q inb12b25_20090217.htm 0001016504-09-000002 001-31668 09614833 34 23391
2008-12-29 3 PRIMARY DOCUMENT 0001019056-08-001477 3480
2008-12-29 3 xslF345X02/inbs3_williammilmoeex.xml 0001443194-08-000005 6703
2008-12-23 8-K inb8k_20081222.htm 5.02 0001016504-08-000085 001-31668 081266421 34 18025
2008-12-02 8-K inb8k_20081202.htm 5.02 0001016504-08-000083 001-31668 081225031 34 13992
2008-11-17 3 xslF345X02/inbs3_jeffreyleach20081117ex.xml 0001160549-08-000003 7392
2008-11-14 10-Q inb10q_200811142.htm 0001016504-08-000081 001-31668 081192303 34 497491
2008-11-10 8-K inb8k_20081105.htm 5.02,9.01 0001016504-08-000079 001-31668 081174311 34 22011
2008-11-05 DEFR14A inbproxy_2008.htm 0001016504-08-000077 001-31668 081164722 34 501875
2008-10-28 DEF 14A def14a_20081028.htm 0001016504-08-000075 001-31668 081145480 34 430718
2008-10-20 8-K inb8k_20081020.htm 1.01,9.01 0001016504-08-000073 001-31668 081131456 34 223873
2008-10-14 10-K inb10k_200806302.htm 0001016504-08-000071 001-31668 081123256 34 996109
2008-09-29 NT 10-K inb12b_20080929.htm 0001016504-08-000068 001-31668 081094596 34 22418
2008-08-21 SC 13D/A inbsc13da_20080821.htm 0001016504-08-000064 005-52311 081032180 34 245162
2008-08-19 8-K inb8k_20080819.htm 8.01,9.01 0001016504-08-000063 001-31668 081026981 34 24943
2008-08-15 5 xslF345X03/inb5_robertcanarickex.xml 0001382218-08-000001 8156
2008-08-14 5 xslF345X03/inb5_carldesantisex.xml 0001102948-08-000001 9957
2008-08-14 5 xslF345X03/inb5_glennchangex.xml 0001384967-08-000003 12958
2008-08-14 5 xslF345X03/inb5_rivasheppardex.xml 0001064900-08-000001 23109
2008-08-14 5 xslF345X03/inb5_dinamasiex.xml 0001345281-08-000002 8594
2008-08-14 5 xslF345X03/inb5_christinakayex.xml 0001064901-08-000001 23093
2008-08-14 5 xslF345X03/inb5_vidadiyusibovex.xml 0001441871-08-000002 15034
2008-08-14 5 xslF345X03/inb5_robertkayex.xml 0001285612-08-000002 11850
2008-08-14 5 xslF345X03/inb5_geraldkayex.xml 0001053310-08-000002 25713
2008-08-12 DEF 14C def14c_20080812.htm 0001016504-08-000061 001-31668 081008707 34 1238158
2008-08-04 UPLOAD filename1.pdf 0000000000-08-038949 19914
2008-07-31 8-K inb8k_20080731.htm 8.01,9.01 0001016504-08-000059 001-31668 08982235 34 27580
2008-07-28 8-K inb8k_20080728.htm 8.01,9.01 0001016504-08-000057 001-31668 08973141 34 29454
2008-07-17 PRER14C prer14c_20080717.htm 0001016504-08-000055 001-31668 08957718 34 1238086
2008-07-11 PRER14C prer14c_20080708.htm 0001016504-08-000053 001-31668 08949528 34 1238439
2008-06-18 PRER14C prer14c_20080617.htm 0001016504-08-000051 001-31668 08905686 34 1203685
2008-05-23 8-K inb8k_20080523.htm 2.02,9.01 0001016504-08-000049 001-31668 08858946 34 59856
2008-05-21 10-Q inb10q_20080331.htm 0001016504-08-000047 001-31668 08850632 34 398848
2008-05-16 NT 10-Q inb12b_20080515.htm 0001016504-08-000044 001-31668 08840457 34 19108
2008-05-12 8-K inb8k_20080512.htm 5.03,9.01 0001016504-08-000042 001-31668 08823721 34 18814
2008-05-12 PRER14C prer14c_20080506.htm 0001016504-08-000041 001-31668 08823213 34 970526
2008-05-06 424B3 INTEGRATED BIOPHARMA, INC. 0001016504-08-000040 333-149855 08804828 33 89155
2008-05-02 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2008-05-02 16:00:00 9999999995-08-001430 333-149855 08800695 33 2273
2008-04-30 CORRESP filename1.htm 0001016504-08-000038 15674
2008-04-29 S-3/A INTEGRATED BIOPHARMA, INC. 0001016504-08-000036 333-149855 08785709 33 158493
2008-04-25 8-K INTEGRATED BIOPHARMA, INC. 3.01,9.01 0001016504-08-000034 001-31668 08777615 34 51855
2008-04-22 UPLOAD filename1.pdf 0000000000-08-020582 25853
2008-04-17 S-3/A INTEGRATED BIOPHARMA, INC. 0001016504-08-000032 333-149855 08762872 33 50685
2008-04-16 S-3/A INTEGRATED BIOPHARMA, INC. 0001016504-08-000030 333-149855 08760158 33 151219
2008-04-09 DEF 14C INTEGRATED BIOPHARMA, INC. 0001016504-08-000028 001-31668 08747100 34 64041
2008-04-02 PRER14C INTEGRATED BIOPHARMA, INC. 0001016504-08-000026 001-31668 08734100 34 72122
2008-04-02 SC 13G c53009_sc13g.htm 0000930413-08-002187 005-52311 08732961 34 43702
2008-04-01 PRE 14C INTEGRATED BIOPHARMA, INC. 0001016504-08-000024 001-31668 08730481 34 59744
2008-03-27 UPLOAD filename1.pdf 0000000000-08-016185 39227
2008-03-27 UPLOAD filename1.pdf 0000000000-08-016136 37525
2008-03-21 S-3 INTEGRATED BIOPHARMA, INC. 0001016504-08-000021 333-149855 08705178 33 144861
2008-03-20 PRE 14C INTEGRATED BIOPHARMA, INC. 0001016504-08-000017 001-31668 08702174 34 61540
2008-03-13 UPLOAD filename1.pdf 0000000000-08-013328 34494
2008-03-07 REGDEX AUTO-GENERATED PAPER DOCUMENT 06 9999999997-08-010252 021-65261 08041079 34 1897
2008-03-07 DEF 14C INTEGRATED BIOPHARMA, INC. 0001016504-08-000012 001-31668 08673652 34 820985
2008-02-22 8-K inb8k_20080222.htm 1.01,9.01 0001016504-08-000009 001-31668 08637228 34 1122228
2008-02-19 10-Q INTEGRATED BIOPHARMA, INC. 0001016504-08-000007 001-31668 08627498 34 719710
2008-02-14 NT 10-Q INTEGRATED BIOPHARMA, INC. 0001016504-08-000004 001-31668 08618129 34 27493
2008-02-14 8-K INTEGRATED BIOPHARMA, INC. 5.03,9.01 0001016504-08-000003 001-31668 08617640 34 106455
2007-11-19 8-K INTEGRATED BIOPHARMA, INC. 1.01,8.01,9.01 0001016504-07-000047 001-31668 071256828 34 97663
2007-11-16 10-Q INTEGRATED BIOPHARMA, INC. 0001016504-07-000045 001-31668 071250847 34 289117
2007-11-15 NT 10-Q INTEGRATED BIOPHARMA, INC. 0001016504-07-000044 001-31668 071250408 34 27510
2007-11-14 8-K INTEGRATED BIOPHARMA, INC. 2.02,9.01 0001016504-07-000041 001-31668 071244336 34 44954
2007-10-30 DEF 14A INTEGRATED BIOPHARMA, INC. 0001016504-07-000037 001-31668 071197497 34 304783
2007-10-01 8-K inb8k_20071001.htm 2.02,9.01 0001016504-07-000035 001-31668 071145437 34 54284
2007-09-28 10-K INTEGRATED BIOPHARMA, INC. 0001016504-07-000033 001-31668 071143316 34 674061
2007-09-11 8-K INTEGRATED BIOPHARMA, INC. 5.02,9.01 0001016504-07-000024 001-31668 071110563 34 5749
2007-08-23 RW INTEGRATED BIOPHARMA, INC. 0001016504-07-000022 333-144155 071076372 NE 3354
2007-07-11 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2007-07-11 16:30:00 9999999995-07-002771 333-144155 07975240 33 2273
2007-06-28 S-3 c49229_s3.txt 0000930413-07-005658 333-144155 07947777 33 53585
2007-05-09 10-Q INTEGRATED BIOPHARMA, INC. 0001016504-07-000019 001-31668 07832428 34 140048
2007-04-26 8-K INTEGRATED BIOPHARMA, INC. 2.02,9.01 0001016504-07-000016 001-31668 07791552 34 15489
2007-04-09 8-K INTEGRATED BIOPHARMA, INC. 1.01,2.03,9.01 0001016504-07-000014 001-31668 07755407 34 84988
2007-03-09 8-K INTEGRATED BIOPHARMA, INC. 1.01,3.02,9.01 0001016504-07-000012 001-31668 07683144 34 71169
2007-02-23 5 xslF345X02/p238226827_ex.xml 0000911420-07-000160 7736
2007-02-15 4 xslF345X02/p238307986_ex.xml 0000911420-07-000128 8199
2007-02-15 4 xslF345X02/p238309188_ex.xml 0000911420-07-000127 8213
2007-02-15 4 xslF345X02/p238309182_ex.xml 0000911420-07-000125 8216
2007-02-15 4 xslF345X02/p238309162_ex.xml 0000911420-07-000123 8258
2007-02-14 10-Q INTEGRATED BIOPHARMA, INC. 0001016504-07-000010 001-31668 07618105 34 135289
2007-02-14 SC 13G/A v065073_sc13ga.txt 0001144204-07-007451 005-52311 07613698 34 20027
2007-02-06 CERTNAS AUTO-GENERATED PAPER DOCUMENT 9999999997-07-005610 001-31668 07043603 34 1880
2007-02-05 8-A12B FORM 8-A - INTEGRATED BIOPHARMA, INC. 0001016504-07-000008 001-31668 07580336 34 5893
2007-02-05 25 INTEGRATED BIOPHARMA, INC. 0001016504-07-000007 001-31668 07580330 34 4137
2007-02-05 8-K INTEGRATED BIOPHARMA, INC. 2.02,9.01 0001016504-07-000006 001-31668 07580240 34 16559
2007-01-24 8-K INTEGRATED BIOPHARMA, INC. 3.01,9.01 0001016504-07-000002 001-31668 07549926 34 7659
2006-12-20 SC 13D d238233305.txt 0000911420-06-000795 005-52311 061288927 34 41165

Latest XBRL company facts

One latest value per concept from companyfacts (377 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 31.06M 2026-11-13 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
dei EntityPublicFloat Entity Public Float USD 3.43M 2025-12-31 2026 FY 10-K 2026-09-25 0001437749-26-031241
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 364,100 2025-07-01 2026-06-30 DEF 14A 2026-10-28 0001437749-26-033764
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 360,744 2025-07-01 2026-06-30 DEF 14A 2026-10-28 0001437749-26-033764
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 349,208 2025-07-01 2026-06-30 DEF 14A 2026-10-28 0001437749-26-033764
ecd PeoTotalCompAmt PeoTotalCompAmt USD 350,732 2025-07-01 2026-06-30 DEF 14A 2026-10-28 0001437749-26-033764
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 34 2025-07-01 2026-06-30 DEF 14A 2026-10-28 0001437749-26-033764
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 1.31M 2014-06-30 2014 FY 10-K 2014-09-08 0001016504-14-000008
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.82M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 3,000 2020-03-31 2020 Q3 10-Q 2020-05-13 0001437749-20-010595
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 3.72M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap AccretionExpense Accretion Expense USD 58,000 2018-07-01 2019-06-30 2019 FY 10-K 2019-08-29 0001437749-19-017611
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 1.49M 2025-09-30 2026 Q1 10-Q 2025-11-10 0001437749-25-034076
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 8.49M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 52.00M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 39,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 6,000 2011-07-01 2011-12-31 2012 Q2 10-Q 2012-02-21 0001016504-12-000011
us-gaap AdvertisingExpense Advertising Expense USD 6,000 2018-07-01 2019-06-30 2019 FY 10-K 2019-08-29 0001437749-19-017611
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 290,000 2021-07-01 2022-03-31 2022 Q3 10-Q 2022-05-12 0001437749-22-012079
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 20,000 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 20,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 3,000 2018-07-01 2019-06-30 2020 FY 10-K 2020-09-23 0001437749-20-020123
us-gaap AmortizationOfDeferredCharges Amortization of Deferred Charges USD 49,000 2016-07-01 2017-03-31 2017 Q3 10-Q 2017-05-10 0001437749-17-008597
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 237,000 2013-07-01 2014-06-30 2014 FY 10-K 2014-09-08 0001016504-14-000008
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 104,000 2015-07-01 2016-06-30 2016 FY 10-K 2016-09-02 0001437749-16-038298
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 5.09M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 30,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap Assets Assets USD 24.03M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap AssetsCurrent Assets, Current USD 15.98M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap AssetsHeldForSaleCurrent Assets Held-for-sale, Current (Deprecated 2014-01-31) USD 3.32M 2011-12-31 2012 Q2 10-Q 2012-02-21 0001016504-12-000011
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 8,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap CapitalLeaseObligations Capital Lease Obligations USD 113,000 2020-03-31 2020 Q3 10-Q 2020-05-13 0001437749-20-010595
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 0 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-15 0001437749-23-026022
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 3.12M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 90,000 2019-07-01 2020-03-31 2020 Q3 10-Q 2020-05-13 0001437749-20-010595
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 3.12M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -1.35M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations Cash Provided by (Used in) Operating Activities, Discontinued Operations USD -744,000 2011-07-01 2011-12-31 2012 Q2 10-Q 2012-02-21 0001016504-12-000011
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 4.38M 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap ChangeInUnrealizedGainLossOnFairValueHedgingInstruments Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments (Deprecated 2013-01-31) USD -9,000 2011-07-01 2012-06-30 2012 FY 10-K 2012-10-15 0001016504-12-000022
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/item 0.8 2012-06-30 2012 FY 10-K 2012-10-15 0001016504-12-000022
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.8 2013-06-30 2014 FY 10-K 2014-09-08 0001016504-14-000008
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 500,000 2008-10-14 2013 FY 10-K 2013-09-30 0001016504-13-000011
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 500,000 2013-06-30 2014 FY 10-K 2014-09-08 0001016504-14-000008
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.002 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 50.00M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 31.09M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 31.09M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap CommonStockValue Common Stock, Value, Issued USD 62,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 12,000 2011-07-01 2012-06-30 2012 FY 10-K 2012-10-15 0001016504-12-000022
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 8.23M 2013-07-01 2013-12-31 2014 Q2 10-Q/A 2014-02-13 0001016504-14-000004
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 4.90M 2013-06-30 2013 FY 10-K 2013-09-30 0001016504-13-000011
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 4.50M 2011-06-30 2013 FY 10-K 2013-09-30 0001016504-13-000011
us-gaap CostmethodInvestmentsOtherThanTemporaryImpairment Cost-method Investments, Other than Temporary Impairment USD 358,000 2017-07-01 2018-06-30 2019 FY 10-K 2019-08-29 0001437749-19-017611
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 10.03M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 18.52M 2017-07-01 2017-12-31 2018 Q2 10-Q 2018-02-09 0001437749-18-002159
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 21,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 8.10M 2012-06-01 2012-06-27 2013 FY 10-K 2013-09-30 0001016504-13-000011
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 2.25M 2010-07-01 2011-06-30 2012 FY 10-K 2012-10-15 0001016504-12-000022
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 12.61M 2011-07-01 2012-06-30 2012 FY 10-K 2012-10-15 0001016504-12-000022
us-gaap DebtDefaultLongtermDebtAmount Debt Instrument, Debt Default, Amount USD 4.50M 2012-06-30 2012 FY 10-K 2012-10-15 0001016504-12-000022
us-gaap DebtInstrumentBasisSpreadOnVariableRate Debt Instrument, Basis Spread on Variable Rate (Deprecated 2013-01-31) pure 0.038 2012-06-30 2012 FY 10-K 2012-10-15 0001016504-12-000022
us-gaap DebtInstrumentBasisSpreadOnVariableRate1 Debt Instrument, Basis Spread on Variable Rate pure 0.038 2012-07-01 2013-06-30 2013 FY 10-K 2013-09-30 0001016504-13-000011
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 2 2012-06-27 2013 FY 10-K 2013-09-30 0001016504-13-000011
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.095 2011-06-30 2013 FY 10-K 2013-09-30 0001016504-13-000011
us-gaap DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment USD 41,000 2016-02-19 2019 Q1 10-Q 2018-11-09 0001437749-18-020336
us-gaap DebtInstrumentPeriodicPaymentPrincipal Debt Instrument, Periodic Payment, Principal USD 44,000 2012-07-01 2013-06-30 2012 FY 10-K 2012-10-15 0001016504-12-000022
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 163,000 2011-06-30 2013 FY 10-K 2013-09-30 0001016504-13-000011
us-gaap DebtInstrumentUnamortizedPremium Debt Instrument, Unamortized Premium USD 805,000 2008-10-14 2013 FY 10-K 2013-09-30 0001016504-13-000011
us-gaap DebtRelatedCommitmentFeesAndDebtIssuanceCosts Debt Related Commitment Fees and Debt Issuance Costs USD 1.10M 2011-07-01 2012-06-30 2012 FY 10-K 2012-10-15 0001016504-12-000022
us-gaap DebtWeightedAverageInterestRate Debt, Weighted Average Interest Rate pure 0.052 2018-06-30 2018 FY 10-K 2018-09-12 0001437749-18-016922
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 169,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap DeferredFederalStateAndLocalTaxExpenseBenefit Deferred Federal, State and Local, Tax Expense (Benefit) USD 55,000 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-15 0001437749-23-026022
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 0 2022-06-30 2022 FY 10-K 2022-09-13 0001437749-22-022334
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 3.31M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -236,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 63,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 250,000 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap DeferredTaxAssetsDerivativeInstruments Deferred Tax Assets, Derivative Instruments USD 192,000 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 5.83M 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 105,000 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap DeferredTaxAssetsInvestments Deferred Tax Assets, Investments USD 186,000 2022-06-30 2022 FY 10-K 2022-09-13 0001437749-22-022334
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 3.08M 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap DeferredTaxAssetsLiabilitiesNetCurrent Deferred Tax Assets, Net, Current USD 0 2014-06-30 2014 FY 10-K 2014-09-08 0001016504-14-000008
us-gaap DeferredTaxAssetsLiabilitiesNetNoncurrent Deferred Tax Assets, Net, Noncurrent USD 577,000 2019-12-31 2020 Q2 10-Q 2020-02-12 0001437749-20-002475
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2013-06-30 2013 FY 10-K 2013-09-30 0001016504-13-000011
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 0 2013-06-30 2013 FY 10-K 2013-09-30 0001016504-13-000011
us-gaap DeferredTaxAssetsNetNoncurrent Deferred Tax Assets, Net of Valuation Allowance, Noncurrent USD 0 2013-06-30 2013 FY 10-K 2013-09-30 0001016504-13-000011
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 5.07M 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 143,000 2018-06-30 2018 FY 10-K 2018-09-12 0001437749-18-016922
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD -137,000 2014-06-30 2014 FY 10-K 2014-09-08 0001016504-14-000008
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 212,000 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 2.56M 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 199,000 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 91,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 160,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap Depreciation Depreciation USD 67,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 91,000 2015-07-01 2015-09-30 2016 Q1 10-Q 2015-11-05 0001016504-15-000014
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 67,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 9,000 2018-07-01 2019-03-31 2020 Q3 10-Q 2020-05-13 0001437749-20-010595
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 503,000 2017-06-30 2018 FY 10-K 2018-09-12 0001437749-18-016922
us-gaap DilutiveSecurities Dilutive Securities, Effect on Basic Earnings Per Share USD -494,000 2017-07-01 2018-06-30 2019 FY 10-K 2019-08-29 0001437749-19-017611
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.02 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.05 2012-07-01 2012-09-30 2013 Q1 10-Q 2012-11-19 0001016504-12-000030
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.02 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.109 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2024-07-01 2025-06-30 2025 FY 10-K 2025-09-23 0001437749-25-029711
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.301 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2018-07-01 2019-06-30 2019 FY 10-K 2019-08-29 0001437749-19-017611
us-gaap EffectiveIncomeTaxRateReconciliationDispositionOfBusiness Effective Income Tax Rate Reconciliation, Disposition of Business, Percent pure 0 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-20 0001437749-24-029768
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0.006 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-20 0001437749-24-029768
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.005 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.001 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0.039 2024-07-01 2025-06-30 2025 FY 10-K 2025-09-23 0001437749-25-029711
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure 0 2024-07-01 2025-06-30 2025 FY 10-K 2025-09-23 0001437749-25-029711
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure 0.023 2024-07-01 2025-06-30 2025 FY 10-K 2025-09-23 0001437749-25-029711
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.083 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability Embedded Derivative, Fair Value of Embedded Derivative Liability USD 0 2013-06-30 2013 FY 10-K 2013-09-30 0001016504-13-000011
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 616,000 2022-03-31 2022 Q3 10-Q 2022-05-12 0001437749-22-012079
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 15,000 2017-06-30 2017 FY 10-K 2017-09-01 0001437749-17-015520
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.06 2013-09-30 2014 Q1 10-Q 2013-11-14 0001016504-13-000017
us-gaap EquityMethodInvestmentQuotedMarketValue Equity Method Investment, Quoted Market Value USD 500,000 2013-09-30 2014 Q1 10-Q 2013-11-14 0001016504-13-000017
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 0 2021-07-01 2022-06-30 2022 FY 10-K 2022-09-13 0001437749-22-022334
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 2,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 104,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 48,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 55,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 112,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 41,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 0 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 8,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 9,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 54,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 2,000 2025-03-31 2025 Q3 10-Q 2025-05-14 0001437749-25-016802
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 8,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 12,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 137,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 7,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 2.18M 2016-06-30 2016 FY 10-K 2016-09-02 0001437749-16-038298
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 251,000 2015-06-30 2015 FY 10-K 2015-09-04 0001016504-15-000010
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 101,000 2016-06-30 2016 FY 10-K 2016-09-02 0001437749-16-038298
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 24,000 2015-06-30 2016 Q3 10-Q 2016-05-13 0001016504-16-000022
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 93,000 2015-06-30 2016 Q3 10-Q 2016-05-13 0001016504-16-000022
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 97,000 2015-06-30 2016 Q3 10-Q 2016-05-13 0001016504-16-000022
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 33,000 2016-06-30 2016 FY 10-K 2016-09-02 0001437749-16-038298
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 101,000 2016-06-30 2016 FY 10-K 2016-09-02 0001437749-16-038298
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 2.42M 2016-06-30 2016 FY 10-K 2016-09-02 0001437749-16-038298
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 235,000 2016-06-30 2016 FY 10-K 2016-09-02 0001437749-16-038298
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 3,000 2014-07-01 2015-03-31 2015 Q3 10-Q 2015-05-14 0001016504-15-000006
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 3,000 2014-07-01 2015-03-31 2015 Q3 10-Q 2015-05-14 0001016504-15-000006
us-gaap GainLossOnDispositionOfProperty Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) USD 244,000 2012-07-01 2013-03-31 2013 Q3 10-Q 2013-05-15 0001016504-13-000006
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD -152,000 2013-07-01 2014-06-30 2015 FY 10-K 2015-09-04 0001016504-15-000010
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD 48,000 2014-07-01 2015-06-30 2016 FY 10-K 2016-09-02 0001437749-16-038298
us-gaap GainLossOnSaleOfProperties Gain (Loss) on Sale of Properties USD 4,000 2013-07-01 2014-03-31 2014 Q3 10-Q 2014-05-14 0001016504-14-000006
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 6,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2021-07-01 2022-06-30 2022 FY 10-K 2022-09-13 0001437749-22-022334
us-gaap GrossProfit Gross Profit USD -112,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap GuaranteeObligationsCurrentCarryingValue Guarantor Obligations, Current Carrying Value USD 1.00M 2013-10-31 2014 Q2 10-Q/A 2014-02-13 0001016504-14-000004
us-gaap GuaranteeObligationsMaximumExposure Guarantor Obligations, Maximum Exposure, Undiscounted USD 1.00M 2013-10-31 2015 FY 10-K 2015-09-04 0001016504-15-000010
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 0 2014-07-01 2014-09-30 2015 Q1 10-Q 2014-11-07 0001016504-14-000013
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-20 0001437749-24-029768
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2014-07-01 2015-06-30 2015 FY 10-K 2015-09-04 0001016504-15-000010
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -89,000 2011-07-01 2011-12-31 2012 Q2 10-Q 2012-02-21 0001016504-12-000011
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -923,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD 7.25M 2020-07-01 2021-06-30 2021 FY 10-K 2021-09-02 0001437749-21-021375
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares 0 2011-07-01 2011-12-31 2012 Q2 10-Q 2012-02-21 0001016504-12-000011
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -333,000 2011-07-01 2011-12-31 2012 Q2 10-Q 2012-02-21 0001016504-12-000011
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent USD 333,000 2011-07-01 2011-12-31 2012 Q2 10-Q 2012-02-21 0001016504-12-000011
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share USD/shares -0.02 2011-07-01 2011-12-31 2012 Q2 10-Q 2012-02-21 0001016504-12-000011
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD -12,000 2018-07-01 2019-03-31 2019 Q3 10-Q 2019-05-15 0001437749-19-010014
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2025-07-01 2026-03-31 2026 Q3 10-Q 2026-05-08 0001437749-26-015899
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 37,000 2023-07-01 2024-03-31 2024 Q3 10-Q 2024-05-10 0001437749-24-016015
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2025-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -232,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD 779,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap IncomeTaxExpenseBenefitContinuingOperationsGovernmentGrants Income Tax (Expense) Benefit, Continuing Operations, Government Grants USD 23,000 2020-07-01 2021-06-30 2021 FY 10-K 2021-09-02 0001437749-21-021375
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 772,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 1,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 13,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 2,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -213,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -378,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 386,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -428,000 2012-07-01 2013-06-30 2013 FY 10-K 2013-09-30 0001016504-13-000011
us-gaap IncreaseDecreaseInDepositOtherAssets Increase (Decrease) in Deposit Assets USD 30,000 2025-07-01 2026-03-31 2026 Q3 10-Q 2026-05-08 0001437749-26-015899
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 12,000 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-20 0001437749-24-029768
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -597,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -284,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 17,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 270,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 201,000 2023-07-01 2023-09-30 2024 Q1 10-Q 2023-11-09 0001437749-23-031168
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD 119,000 2014-07-01 2014-09-30 2015 Q1 10-Q 2014-11-07 0001016504-14-000013
us-gaap IncreaseDecreaseInSecurityDeposits Increase (Decrease) in Security Deposits USD 18,000 2019-07-01 2019-09-30 2020 Q1 10-Q 2019-11-13 0001437749-19-022660
us-gaap IncrementalCommonSharesAttributableToContingentlyIssuableShares Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares shares 219,581 2012-10-01 2012-12-31 2013 Q2 10-Q 2013-02-19 0001016504-13-000004
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 8.23M 2018-07-01 2019-06-30 2020 FY 10-K 2020-09-23 0001437749-20-020123
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap InterestCostsCapitalizedAdjustment Interest Costs Capitalized Adjustment USD 54,000 2013-07-01 2013-12-31 2014 Q2 10-Q/A 2014-02-13 0001016504-14-000004
us-gaap InterestCostsIncurred Interest Costs Incurred USD -164,000 2013-07-01 2013-12-31 2014 Q2 10-Q/A 2014-02-13 0001016504-14-000004
us-gaap InterestExpense Interest Expense USD 12,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap InterestExpenseLesseeAssetsUnderCapitalLease Interest Expense, Lessee, Assets under Capital Lease USD 2,000 2020-07-01 2021-06-30 2021 FY 10-K 2021-09-02 0001437749-21-021375
us-gaap InterestExpenseLongTermDebt Interest Expense, Long-term Debt USD 19,000 2020-07-01 2021-06-30 2021 FY 10-K 2021-09-02 0001437749-21-021375
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD -112,000 2025-07-01 2026-03-31 2026 Q3 10-Q 2026-05-08 0001437749-26-015899
us-gaap InterestExpenseOther Interest Expense, Other USD 0 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-15 0001437749-23-026022
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 17,000 2011-07-01 2012-06-30 2012 FY 10-K 2012-10-15 0001016504-12-000022
us-gaap InterestExpenseSubordinatedNotesAndDebentures Interest Expense, Subordinated Notes and Debentures USD 12,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap InterestExpenseTradingLiabilities Interest Expense, Trading Liabilities USD 1,000 2011-07-01 2012-06-30 2012 FY 10-K 2012-10-15 0001016504-12-000022
us-gaap InterestOnConvertibleDebtNetOfTax Interest on Convertible Debt, Net of Tax USD 216,000 2017-07-01 2018-06-30 2019 FY 10-K 2019-08-29 0001437749-19-017611
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 333,000 2012-06-01 2012-06-27 2019 FY 10-K 2019-08-29 0001437749-19-017611
us-gaap InterestPaidCapitalized Interest Paid, Capitalized, Investing Activities USD 1,000 2011-07-01 2012-06-30 2012 FY 10-K 2012-10-15 0001016504-12-000022
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 2 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 0 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 1.08M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap InventoryNet Inventory, Net USD 8.54M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 5.76M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 1.71M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap InvestmentIncomeInterestAndDividend Investment Income, Interest and Dividend USD 1,000 2011-07-01 2012-06-30 2012 FY 10-K 2012-10-15 0001016504-12-000022
us-gaap InvestmentIncomeNonoperating Investment Income, Nonoperating USD 154,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap InvestmentOwnedAtFairValue Investment Owned, at Fair Value USD 12,000 2022-06-30 2023 FY 10-K 2023-09-15 0001437749-23-026022
us-gaap InvestmentOwnedBalanceShares Investment Owned, Balance, Shares shares 1.27M 2013-09-30 2014 Q1 10-Q 2013-11-14 0001016504-13-000017
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 242,000 2017-07-01 2017-09-30 2018 Q1 10-Q 2017-11-09 0001437749-17-018907
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.038 2018-12-31 2019 Q2 10-Q 2019-02-13 0001437749-19-002460
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 1.40M 2024-12-31 2025 Q2 10-Q 2025-02-13 0001437749-25-003744
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 2.59M 2021-06-30 2021 FY 10-K 2021-09-02 0001437749-21-021375
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 661,000 2024-12-31 2025 Q2 10-Q 2025-02-13 0001437749-25-003744
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 316,000 2021-06-30 2021 FY 10-K 2021-09-02 0001437749-21-021375
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 542,000 2021-06-30 2021 FY 10-K 2021-09-02 0001437749-21-021375
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 64,000 2024-12-31 2025 Q2 10-Q 2025-02-13 0001437749-25-003744
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 169,000 2024-12-31 2025 Q2 10-Q 2025-02-13 0001437749-25-003744
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 506,000 2024-12-31 2025 Q2 10-Q 2025-02-13 0001437749-25-003744
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 77,000 2024-12-31 2025 Q2 10-Q 2025-02-13 0001437749-25-003744
us-gaap Liabilities Liabilities USD 7.01M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 24.03M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap LiabilitiesCurrent Liabilities, Current USD 5.45M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap LiabilitiesOfAssetsHeldForSale Liabilities of Assets Held-for-sale (Deprecated 2014-01-31) USD 1.96M 2011-12-31 2012 Q2 10-Q 2012-02-21 0001016504-12-000011
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap LineOfCreditFacilityAmountOutstanding Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) USD -4.34M 2013-09-30 2014 Q1 10-Q 2013-11-14 0001016504-13-000017
us-gaap LineOfCreditFacilityInterestRateAtPeriodEnd Line of Credit Facility, Interest Rate at Period End pure 0.033 2014-06-30 2014 FY 10-K 2014-09-08 0001016504-14-000008
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 4.34M 2013-09-30 2014 Q1 10-Q 2013-11-14 0001016504-13-000017
us-gaap LineOfCreditFacilityRemainingBorrowingCapacity Line of Credit Facility, Remaining Borrowing Capacity USD 1.40M 2012-06-30 2012 FY 10-K 2012-10-15 0001016504-12-000022
us-gaap LinesOfCreditCurrent Line of Credit, Current USD 0 2023-06-30 2023 FY 10-K 2023-09-15 0001437749-23-026022
us-gaap LongTermDebt Long-term Debt USD 0 2023-06-30 2023 FY 10-K 2023-09-15 0001437749-23-026022
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 18,000 2024-03-31 2024 Q3 10-Q 2024-05-10 0001437749-24-016015
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 0 2024-03-31 2024 Q3 10-Q 2024-05-10 0001437749-24-016015
us-gaap LongTermLineOfCredit Long-term Line of Credit, Noncurrent USD 4.88M 2016-09-30 2017 Q1 10-Q 2016-11-10 0001437749-16-041746
us-gaap LongTermLoansPayable Loans Payable, Noncurrent USD 3.73M 2012-06-27 2016 Q1 10-Q 2015-11-05 0001016504-15-000014
us-gaap LossContingencyEstimateOfPossibleLoss Loss Contingency, Estimate of Possible Loss USD 600,000 2012-05-15 2013 FY 10-K 2013-09-30 0001016504-13-000011
us-gaap NetCashProvidedByUsedInDiscontinuedOperations Net Cash Provided by (Used in) Discontinued Operations USD 103,000 2011-07-01 2011-12-31 2012 Q2 10-Q 2012-02-21 0001016504-12-000011
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -12,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -333,000 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-01 0001437749-17-015520
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -124,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -327,000 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-01 0001437749-17-015520
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -1.22M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 397,000 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-01 0001437749-17-015520
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -691,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap NetIncomeLossAttributableToParentDiluted Net Income (Loss) Attributable to Parent, Diluted USD 1.69M 2018-07-01 2019-06-30 2019 FY 10-K 2019-08-29 0001437749-19-017611
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -155,000 2012-07-01 2012-12-31 2013 Q2 10-Q 2013-02-19 0001016504-13-000004
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 142,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap NotesPayable Notes Payable USD 7.80M 2012-06-30 2012 FY 10-K 2012-10-15 0001016504-12-000022
us-gaap NotesPayableCurrent Notes Payable, Current USD 7.80M 2011-10-01 2013 FY 10-K 2013-09-30 0001016504-13-000011
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 5.27M 2018-07-01 2019 FY 10-K 2019-08-29 0001437749-19-017611
us-gaap NotesPayableRelatedPartiesNoncurrent Notes Payable, Related Parties, Noncurrent USD 5.22M 2017-06-30 2018 FY 10-K 2018-09-12 0001437749-18-016922
us-gaap NotesReduction Notes Reduction USD 5.35M 2011-07-01 2012-06-30 2013 FY 10-K 2013-09-30 0001016504-13-000011
us-gaap NumberOfReportableSegments Number of Reportable Segments pure 2 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -961,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap OperatingLeaseCost Operating Lease, Cost USD 333,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 1.54M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 2.96M 2026-03-31 2026 Q3 10-Q 2026-05-08 0001437749-26-015899
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.18M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 1.50M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap OperatingLeasePayments Operating Lease, Payments USD 318,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 2.63M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 306,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 4.30M 2018-06-30 2018 FY 10-K 2018-09-12 0001437749-18-016922
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 608,000 2017-06-30 2017 FY 10-K 2017-09-01 0001437749-17-015520
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 571,000 2018-06-30 2018 FY 10-K 2018-09-12 0001437749-18-016922
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 584,000 2018-06-30 2018 FY 10-K 2018-09-12 0001437749-18-016922
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 585,000 2018-06-30 2018 FY 10-K 2018-09-12 0001437749-18-016922
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 607,000 2018-06-30 2018 FY 10-K 2018-09-12 0001437749-18-016922
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 1.96M 2017-06-30 2017 FY 10-K 2017-09-01 0001437749-17-015520
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 157,000 2018-03-31 2018 Q3 10-Q 2018-05-09 0001437749-18-009219
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 507,000 2019-07-01 2019-12-31 2020 Q2 10-Q 2020-02-12 0001437749-20-002475
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 2.14M 2012-03-31 2012 Q3 10-Q 2012-05-21 0001016504-12-000015
us-gaap OtherAssetsCurrent Other Assets, Current USD 595,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap OtherExpenses Other Expenses USD 217,000 2012-06-01 2012-06-27 2019 FY 10-K 2019-08-29 0001437749-19-017611
us-gaap OtherIncome Other Income USD 13,000 2011-07-01 2012-06-30 2012 FY 10-K 2012-10-15 0001016504-12-000022
us-gaap OtherLongTermNotesPayable Other Notes Payable, Noncurrent USD 11.73M 2012-06-30 2012 FY 10-K 2012-10-15 0001016504-12-000022
us-gaap OtherNoncashExpense Other Noncash Expense USD 53,000 2011-07-01 2012-06-30 2013 FY 10-K 2013-09-30 0001016504-13-000011
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 143,000 2014-07-01 2015-03-31 2015 Q3 10-Q 2015-05-14 0001016504-15-000006
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 38,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap OtherOperatingActivitiesCashFlowStatement Other Operating Activities, Cash Flow Statement USD 0 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap PaymentsOfDebtRestructuringCosts Payments of Debt Restructuring Costs USD 87,000 2008-10-01 2008-10-04 2013 FY 10-K 2013-09-30 0001016504-13-000011
us-gaap PaymentsToAcquireEquipmentOnLease Payments to Acquire Equipment on Lease USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap PaymentsToAcquireEquityMethodInvestments Payments to Acquire Equity Method Investments USD 8,000 2018-07-01 2019-06-30 2020 FY 10-K 2020-09-23 0001437749-20-020123
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 116,000 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-15 0001437749-23-026022
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 124,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 1,000 2008-02-21 2012 FY 10-K 2012-10-15 0001016504-12-000022
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 17.34M 2008-02-01 2008-02-21 2013 FY 10-K 2013-09-30 0001016504-13-000011
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 54.62M 2021-07-01 2022-06-30 2022 FY 10-K 2022-09-13 0001437749-22-022334
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 1.64M 2019-07-01 2020-06-30 2021 FY 10-K 2021-09-02 0001437749-21-021375
us-gaap ProceedsFromRepaymentsOfLinesOfCredit Proceeds from (Repayments of) Lines of Credit USD -101,000 2022-07-01 2023-03-31 2023 Q3 10-Q 2023-05-11 0001437749-23-013885
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 0 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-20 0001437749-24-029768
us-gaap ProceedsFromSaleOfLongtermInvestments Proceeds from Sale of Long-term Investments USD 79,000 2014-07-01 2015-06-30 2016 FY 10-K 2016-09-02 0001437749-16-038298
us-gaap ProceedsFromSaleOfMachineryAndEquipment Proceeds from Sale of Machinery and Equipment USD 19,000 2012-07-01 2013-06-30 2013 FY 10-K 2013-09-30 0001016504-13-000011
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 6,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap ProceedsFromSecuredLinesOfCredit Proceeds from Secured Lines of Credit USD 43,000 2015-07-01 2016-06-30 2017 FY 10-K 2017-09-01 0001437749-17-015520
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap ProfessionalFees Professional Fees USD 1.10M 2011-07-01 2012-06-30 2012 FY 10-K 2012-10-15 0001016504-12-000022
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 913,000 2013-07-01 2013-12-31 2014 Q2 10-Q/A 2014-02-13 0001016504-14-000004
us-gaap PropertyPlantAndEquipmentDisposals Property, Plant and Equipment, Disposals USD 267,000 2022-07-01 2023-03-31 2023 Q3 10-Q 2023-05-11 0001437749-23-013885
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 10.30M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.81M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD 0 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-20 0001437749-24-029768
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 0 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-20 0001437749-24-029768
us-gaap RepaymentsOfLongTermCapitalLeaseObligations Repayments of Long-term Capital Lease Obligations USD 75,000 2020-07-01 2021-06-30 2021 FY 10-K 2021-09-02 0001437749-21-021375
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 0 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-15 0001437749-23-026022
us-gaap RestrictedCashAndInvestmentsCurrent Restricted Cash and Investments, Current USD 465,000 2017-06-30 2017 FY 10-K 2017-09-01 0001437749-17-015520
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -34.95M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 9.91M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap Revenues Revenues USD 10.30M 2018-07-01 2018-09-30 2019 Q1 10-Q 2018-11-09 0001437749-18-020336
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 3.14M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap SaleLeasebackTransactionNetProceedsFinancingActivities Sale Leaseback Transaction, Net Proceeds, Financing Activities USD 233,000 2018-07-01 2019-06-30 2020 FY 10-K 2020-09-23 0001437749-20-020123
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 20.57M 2017-07-01 2017-12-31 2018 Q2 10-Q 2018-02-09 0001437749-18-002159
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 20.57M 2017-07-01 2017-12-31 2018 Q2 10-Q 2018-02-09 0001437749-18-002159
us-gaap SegmentExpenditureAdditionToLongLivedAssets SegmentExpenditureAdditionToLongLivedAssets USD 124,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 849,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap SeniorNotes Senior Notes USD 11.73M 2012-06-27 2016 Q1 10-Q 2015-11-05 0001016504-15-000014
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 39,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.317 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-13 0001437749-24-034953
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.04 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-13 0001437749-24-034953
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 6.00M 2017-07-01 2018-06-30 2018 FY 10-K 2018-09-12 0001437749-18-016922
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 13.00M 2018-06-30 2018 FY 10-K 2018-09-12 0001437749-18-016922
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 6.35M 2024-06-30 2024 FY 10-K 2024-09-20 0001437749-24-029768
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 3.95M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 0.4 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 41,834 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 28,333 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 726,500 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 2,000 2011-06-30 2012 FY 10-K 2012-10-15 0001016504-12-000022
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 5.09M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 0.38 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 0.54 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 0.3 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0.29 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit USD/shares 0.18 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit USD/shares 0.95 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap SharePrice Share Price USD/shares 0.32 2026-03-31 2026 Q3 10-Q 2026-05-08 0001437749-26-015899
us-gaap ShippingHandlingAndTransportationCosts Shipping, Handling and Transportation Costs (Deprecated 2018-01-31) USD 296,000 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-01 0001437749-17-015520
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 17.02M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 200,000 2008-02-01 2008-02-21 2013 FY 10-K 2013-09-30 0001016504-13-000011
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 5.27M 2018-07-01 2019-06-30 2020 FY 10-K 2020-09-23 0001437749-20-020123
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 14,000 2011-07-01 2012-06-30 2013 FY 10-K 2013-09-30 0001016504-13-000011
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD -12,000 2011-07-01 2012-06-30 2012 FY 10-K 2012-10-15 0001016504-12-000022
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture USD 24,000 2018-10-01 2018-12-31 2020 Q2 10-Q 2020-02-12 0001437749-20-002475
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 86,000 2024-07-01 2025-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 104,000 2014-07-01 2015-06-30 2015 FY 10-K 2015-09-04 0001016504-15-000010
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 30,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-25 0001437749-26-031241
us-gaap TaxAdjustmentsSettlementsAndUnusualProvisions Tax Adjustments, Settlements, and Unusual Provisions USD 202,000 2018-07-01 2019-06-30 2019 FY 10-K 2019-08-29 0001437749-19-017611
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 34,900 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 99,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap TreasuryStockShares Treasury Stock, Shares shares 34,900 2022-12-31 2023 Q2 10-Q 2023-02-10 0001437749-23-003051
us-gaap TreasuryStockValue Treasury Stock, Value USD 99,000 2022-12-31 2023 Q2 10-Q 2023-02-10 0001437749-23-003051
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 0 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-20 0001437749-24-029768
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -18,000 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-15 0001437749-23-026022
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 2.59M 2021-07-01 2022-03-31 2022 Q3 10-Q 2022-05-12 0001437749-22-012079
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 31.06M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 21.01M 2011-07-01 2012-06-30 2012 FY 10-K 2012-10-15 0001016504-12-000022
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 31.06M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001437749-26-036725

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →